TrialOncotarget2017

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea.

Doo-Sik Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.